Document Type : Original Research Article


PhD Research Scholar Department of Pharmaceutical Sciences University of Kashmir, J & K India, 190006



To estimate quercetin in ophthalmic formulations, an accurate and simple UV spectroscopic method has been developed. Quercetin shows absorbance maximum at 255 in the ethanol. In the concentration range of 3 -18 μg/mL, Beer Lamberts law was obeyed. This method is useful for a regular estimation of quercetin in ophthalmic formulations like eye drops and other formulations are used for the treatment of ophthalmic diseases having quercetin as an active pharmaceutical ingredient which was developed and validated as the underlying method per the guidelines by ICH.

Graphical Abstract

Development of UV Spectrophotometric Method for Quantitative Estimation of Quercetin in Ocular Formulations


Main Subjects

[1] G.A. Stevens, R.A. White, S.R. Flaxman, H. Price, J.B. Jonas, J. Keeffe, J. Leasher, K. Naidoo, K. Pesudovs, S. Resnikoff, H. Taylor, R. Bourne, Global prevalence of vision impairment and blindness: magnitude and temporal trends, 1990–2010, Ophthalmology, 120 (12) (2013) 2377–2384.
[2] N. Bodor, P. Buchwald, Ophthalmic drug design based on the metabolic activity of the eye: soft drugs and chemical delivery systems, AAPS J., 7 (4) (2005) E820–E833.
[3] M.C. Coroi, S. Bungau, M. Tit, Preservatives from the eye drops and the ocular surface, Rom. J. Ophthalmol., 59 (1) (2015) 2–5.
[4] P. Baranowski, B. Karolewicz, M. Gajda, J. Pluta, Ophthalmic drug dosage forms: characterisation and research methods, Sci. World J., 2014 (2014) 1–14.
[5] A. Yeung, N.T. Tzvetkov, O.S. El-Tawil, S.G. Bungǎu, M.M. Abdel-Daim, A. G. Atanasov, Antioxidants: scientific literature landscape analysis, Oxid. Med. Cell. Longev., 2019 (2019) 1–11.
[6] Y. Li, J. Yao, C. Han, J. Yang, M.T. Chaudhry, S. Wang, H. Liu, Y. Yin, Quercetin, inflammation and immunity, Nutrients, 8 (3) (2016) 167.
[7] R.V. Patel, B.M. Mistry, S.K. Shinde, R. Syed, V. Singh, H.S. Shin, Therapeutic potential of quercetin as a cardiovascular agent, Eur. J. Med. Chem., 155 (2018) 889–904.
[8] X.J. Wu, X.B. Zhou, C. Chen, W. Mao, Systematic investigation of quercetin for treating cardiovascular disease based on network pharmacology, Comb. Chem. High Throughput Screen., 22 (6) (2019) 411–420.
[9] J.S. Nam, A.R. Sharma, L.T. Nguyen, C. Chakraborty, G. Sharma, S.S. Lee, Application of bioactive quercetin in oncotherapy: from nutrition to nanomedicine, Molecules, 21 (1) (2016) 108.
[10] L.G. Costa, J.M. Garrick, P.J. Roqu`e, C. Pellacani, Mechanisms of neuroprotection by quercetin: counteracting oxidative stress and more, Oxid. Med. Cell. Longev., 2016 (2016) 1–10.
[11] T.B. McKay, D. Karamichos, Quercetin and the ocular surface: what we know and where we are going, Exp. Biol. Med., 242 (6) (2017) 565–572.
[12] T. Hirano, M. Kawai, J. Arimitsu, M. Ogawa, Y. Kuwahara, K. Hagihara, Y. Shima, M. Narazaki, A. Ogata, M. Koyanagi, Preventative effect of a flavonoid, enzymatically modified isoquercitrin on ocular symptoms of Japanese cedar pollinosis, Allergol. Int., 58 (3) (2009) 373–382.
[13] T.B. McKay, D. Lyon, A. Sarker-Nag, S. Priyadarsini, J.M. Asara, D. Karamichos, Quercetin attenuates lactate production and extracellular matrix secretion in keratoconus, Sci. Rep., 5 (2015) 9003.
[14] J.S. Yoon, H.J. Lee, S.H. Choi, E.J. Chang, S.Y. Lee, E.J. Lee, Quercetin inhibits IL- 1β-induced inflammation, hyaluronan production and adipogenesis in orbital fibroblasts from Graves’ orbitopathy, PLoS One, 6 (10) (2011), e26261.
[15] W. Song, X. Zhao, J. Xu, H. Zhang, Quercetin inhibits angiogenesis-mediated human retinoblastoma growth by targeting vascular endothelial growth factor receptor, Oncol. Lett., 14 (3) (2017) 3343–3348.